NEURAXIS, INC. (NRXS) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 3.10M USD | Liabilities, Current |
| Cash and equivalents | 8.32M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 432.93K USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 277.31K USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $3.10M | $8.32M | (m) | $432.93K | $277.31K | (m) |
| 2026-03-31 | (m) | $2.81M | $7.08M | (m) | $385.01K | $238.28K | (m) |
| 2025-12-31 | (m) | $2.79M | $4.97M | (m) | $195.70K | $257.13K | (m) |
| 2025-09-30 | (m) | $3.15M | $4.38M | (m) | $108.50K | $110.26K | (m) |
| 2025-06-30 | (m) | $2.35M | $5.99M | (m) | $128.52K | $131.43K | (m) |
| 2025-03-31 | (m) | $2.10M | $2.01M | (m) | $243.71K | $37.42K | (m) |
| 2024-12-31 | (m) | $2.43M | $3.70M | (m) | $244.62K | $44.33K | (m) |
| 2024-09-30 | (m) | $2.66M | $260.88K | (m) | $52.59K | $22.46K | (m) |
| 2024-06-30 | (m) | $7.59M | $1.77M | (m) | $147.13K | $42.71K | (m) |
| 2024-03-31 | (m) | $3.82M | $81.75K | (m) | $90.53K | $20.19K | (m) |
| 2023-12-31 | (m) | $1.89M | $78.56K | (m) | $73.17K | $21.22K | (m) |
| 2023-09-30 | (m) | $2.26M | $761.25K | (m) | $132.38K | $34.53K | (m) |
| 2023-06-30 | (m) | $11.43M | $51.44K | (m) | $237.17K | $44.20K | (m) |
| 2022-12-31 | (m) | $6.98M | $253.70K | (m) | $174.40K | $48.13K | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | $115.30K | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |